CAPR
Price
$14.23
Change
+$1.05 (+7.97%)
Updated
Jun 6 closing price
Capitalization
602.43M
59 days until earnings call
GENFF
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
May 27 closing price
Capitalization
5.22M
Interact to see
Advertisement

CAPR vs GENFF

Header iconCAPR vs GENFF Comparison
Open Charts CAPR vs GENFFBanner chart's image
Capricor Therapeutics
Price$14.23
Change+$1.05 (+7.97%)
Volume$2.51M
Capitalization602.43M
Genflow Biosciences
Price$0.01
Change-$0.00 (-0.00%)
Volume$3.33K
Capitalization5.22M
CAPR vs GENFF Comparison Chart
Loading...
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CAPR vs. GENFF commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CAPR is a StrongBuy and GENFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CAPR: $10.65 vs. GENFF: $0.01)
Brand notoriety: CAPR and GENFF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CAPR: 41% vs. GENFF: 57%
Market capitalization -- CAPR: $602.43M vs. GENFF: $5.22M
CAPR [@Biotechnology] is valued at $602.43M. GENFF’s [@Biotechnology] market capitalization is $5.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CAPR’s FA Score shows that 0 FA rating(s) are green whileGENFF’s FA Score has 0 green FA rating(s).

  • CAPR’s FA Score: 0 green, 5 red.
  • GENFF’s FA Score: 0 green, 5 red.
According to our system of comparison, both CAPR and GENFF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CAPR’s TA Score shows that 6 TA indicator(s) are bullish.

  • CAPR’s TA Score: 6 bullish, 4 bearish.

Price Growth

CAPR (@Biotechnology) experienced а -4.23% price change this week, while GENFF (@Biotechnology) price change was +44.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CAPR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CAPR($602M) has a higher market cap than GENFF($5.22M). CAPR YTD gains are higher at: -22.826 vs. GENFF (-75.721).
CAPRGENFFCAPR / GENFF
Capitalization602M5.22M11,541%
EBITDA-34.79MN/A-
Gain YTD-22.826-75.72130%
P/E RatioN/AN/A-
Revenue23.2MN/A-
Total Cash85MN/A-
Total Debt1.65MN/A-
FUNDAMENTALS RATINGS
CAPR: Fundamental Ratings
CAPR
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
76
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CAPR
RSI
ODDS (%)
Bullish Trend 12 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
86%
Momentum
ODDS (%)
Bullish Trend 12 days ago
81%
MACD
ODDS (%)
Bullish Trend 12 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
83%
Advances
ODDS (%)
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend about 1 month ago
85%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
88%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CAPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CAPR and

Correlation & Price change

A.I.dvisor tells us that CAPR and WVE have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CAPR and WVE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CAPR
1D Price
Change %
CAPR100%
+1.62%
WVE - CAPR
31%
Poorly correlated
+1.85%
XNCR - CAPR
31%
Poorly correlated
-2.58%
CCCC - CAPR
31%
Poorly correlated
-3.08%
NKTR - CAPR
30%
Poorly correlated
+3.68%
CORT - CAPR
30%
Poorly correlated
+1.09%
More

GENFF and

Correlation & Price change

A.I.dvisor tells us that GENFF and OTLK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENFF and OTLK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENFF
1D Price
Change %
GENFF100%
N/A
OTLK - GENFF
25%
Poorly correlated
+1.24%
ENTO - GENFF
25%
Poorly correlated
-0.20%
CAPR - GENFF
25%
Poorly correlated
+1.62%
APLIF - GENFF
24%
Poorly correlated
-5.57%
TOVX - GENFF
24%
Poorly correlated
-0.44%
More